PTB: Not just a polypyrimidine tract-binding protein

J Cell Physiol. 2022 May;237(5):2357-2373. doi: 10.1002/jcp.30716. Epub 2022 Mar 14.

Abstract

Polypyrimidine tract-binding protein (PTB), as a member of the heterogeneous nuclear ribonucleoprotein family, functions by rapidly shuttling between the nucleus and the cytoplasm. PTB is involved in the alternative splicing of pre-messenger RNA (mRNA) and almost all steps of mRNA metabolism. PTB regulation is organ-specific; brain- or muscle-specific microRNAs and long noncoding RNAs partially contribute to regulating PTB, thereby modulating many physiological and pathological processes, such as embryonic development, cell development, spermatogenesis, and neuron growth and differentiation. Previous studies have shown that PTB knockout can inhibit tumorigenesis and development. The knockout of PTB in glial cells can be reprogrammed into functional neurons, which shows great promise in the field of nerve regeneration but is controversial.

Keywords: PTB; PTBP1; alternative splicing; development; disease.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing / genetics
  • Heterogeneous-Nuclear Ribonucleoproteins* / genetics
  • Neurons / metabolism
  • Polypyrimidine Tract-Binding Protein* / genetics
  • Polypyrimidine Tract-Binding Protein* / metabolism
  • RNA, Messenger / genetics

Substances

  • Heterogeneous-Nuclear Ribonucleoproteins
  • RNA, Messenger
  • Polypyrimidine Tract-Binding Protein